EPRX earnings: real EPS beat/miss history, analyst consensus Buy, P/E -6.15. Updated 2026-07-23.
Eupraxia Pharmaceuticals (EPRX) Research Hub
Eupraxia Pharmaceuticals (EPRX) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 8.42 USD (+4.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.15, market cap 0.22B. This hub links to the full technical, earnings and options research available for EPRX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 8.42 USD (+4.21%) |
| 52-week range | 5.72 USD – 8.6 USD |
| Trend regime | Range |
| 14-day RSI | 65.8 (Bullish) |
| Trailing P/E | -6.15 |
| Market cap | 0.22B |
| Dividend yield | 0.00% |
Available research for EPRX
Covered Call on EPRX: how it works, illustrative setup around the real 8.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on EPRX: how it works, illustrative setup around the real 8.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on EPRX: how it works, illustrative setup around the real 8.42 USD price, max profit/loss, breakeven and when to use it. Educational.
EPRX technical analysis: range, last 8.42 USD, RSI 65.8, 52w range 5.72 USD–8.6 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is EPRX in?
Eupraxia Pharmaceuticals (EPRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is EPRX in an uptrend or downtrend?
As of 2026-09-11, EPRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is EPRX's trailing P/E ratio?
EPRX's trailing P/E is -6.15, with a market cap of 0.22B. See the earnings research page for full valuation detail.